These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8908093)

  • 21. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes.
    McCaughan GW; Shackel NA; Bertolino P; Bowen DG
    Transplantation; 2009 Apr; 87(8):1105-11. PubMed ID: 19384153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer cells in hepatitis C virus recurrence following liver transplantation: what role do they play?
    de Arias AE; Haworth SE; Defeo TM; Poli F
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):329-32. PubMed ID: 19673619
    [No Abstract]   [Full Text] [Related]  

  • 24. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
    Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
    Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of hepatitis C in the setting of liver transplantation.
    Khalid SK; Crippin JS
    Clin Liver Dis; 2006 May; 10(2):321-37, ix. PubMed ID: 16971264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C recurrence after liver transplantation: is there cause for concern?
    Sorrell MF
    Am J Gastroenterol; 1997 Sep; 92(9):1416-7. PubMed ID: 9317055
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis C virus recurrence after liver transplantation: relationship to anti-HCV core IgM, genotype, and level of viremia.
    Crespo J; Carte B; Lozano JL; Casafont F; Rivero M; de la Cruz F; Pons-Romero F
    Am J Gastroenterol; 1997 Sep; 92(9):1458-62. PubMed ID: 9317062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients.
    Gane E
    Liver Transpl; 2003 Nov; 9(11):S28-34. PubMed ID: 14586892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host and donor risk factors before and after liver transplantation that impact HCV recurrence.
    Berenguer M
    Liver Transpl; 2003 Nov; 9(11):S44-7. PubMed ID: 14586894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation.
    Brillanti S; Vivarelli M; De Ruvo N; Aden AA; Camaggi V; D'Errico A; Furlini G; Bellusci R; Roda E; Cavallari A
    Liver Transpl; 2002 Oct; 8(10):884-8. PubMed ID: 12360428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
    Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
    Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The course of hepatitis C infection after liver transplantation].
    Ołdakowska-Jedynak U; Paczek L
    Pol Merkur Lekarski; 2005 Aug; 19(110):220-4. PubMed ID: 16245439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
    Berenguer M; Prieto M; Palau A; Rayón JM; Carrasco D; Juan FS; López-Labrador FX; Moreno R; Mir J; Berenguer J
    Liver Transpl; 2003 Mar; 9(3):228-35. PubMed ID: 12619018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis.
    Bharat A; Narayanan K; Golocheikine A; Steward N; Crippin J; Lisker-Melman M; Shenoy S; Lowell J; Chapman WC; Mohanakumar T
    Transplantation; 2007 Dec; 84(12):1704-7. PubMed ID: 18165785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Living donor liver transplantation in patients with hepatitis C.
    Zimmerman MA; Trotter JF
    Liver Transpl; 2003 Nov; 9(11):S52-7. PubMed ID: 14586896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.